Struct Chem (2010) 21:955–964
957
CH=CH2 trans, T1A and T1B, respectively), 5.20 (d,
J = 10 Hz, CH=CH2 cis, T2A), 5.32 (d, J = 17 Hz,
CH=CH2 trans, T2A), 5.85–5.95 (2 9 m, CH=CH2, T1A
and T1B), 5.95–6.06 (m, CH=CH2, T2A), 7.15–7.25 (m,
2H, H-3, and H-4), 7.37 (d, J = 7.7 Hz, H-5, T1B), 7.43
(d, J = 7.7 Hz, H-5, T1A), 7.46, 7.50 (2 9 d, J = 7.7 Hz,
H-2 and H-5 for T2A), 7.55 (d, J = 7.7 Hz, H-2, T1B),
7.61 (d, J = 7.7 Hz, H-2, T1A), 8.15 (t, J = 6 Hz, N4–H,
T1A), 8.48 (t, J = 6 Hz, N4–H, T1B), 10.80 (s, N3–H,
T2A), 11.60 (t, J = 6 Hz, N4–H, T2A), 13.10 (s, N2–H,
T1B), 13.25 (s, N2–H, T1A).
1H NMR (CDCl3) d 3.57, 3.55, 3.70 (2 9 s and br s,
CH3, T1B, T1A, and T2A, respectively), 4.20, 4.32, 4.48
(2 9 t and br t, J = 6 Hz, CH2NH, T1A, T1B, and T2A,
respectively), 5.18, 5.21 (2 9 d, J = 10 Hz, CH=CH2 cis,
T1A and T1B, respectively), 5.28, 5.32 (2 9 d,
J = 17 Hz, CH=CH2 trans, T1A and T1B, respectively),
5.90–6.00 (2 9 m, CH=CH2, T1A and T1B), 6.35 (br s,
N4–H, T1A), 6.60 (br s, N4–H, T1B), 7.18–7.36 (m, Ar–H,
T1A and T1B), 13.60 (br s, N2–H, T1A and T1B).
There are additional broad peaks in the spectrum cen-
tered at 3.70, 4.48, 5.40, and 6.05 ppm that correspond to
traces of T2A tautomer (about 3–4%);
-250.5 (N4 for T2A), -247.5 (N4 for T1A), -245.5 (N4
for T1B);
1H NMR (CDCl3) d 3.58 (s, CH3, T1A), 3.70 (br s, CH3,
T1B), 4.78 and 4.90 (2 9 d, J = 6 Hz, CH2NH, T1A
and T1B, respectively), 6.25 (br s, N4–H for T1B), 6.60
(t, N4–H for T1A), 7.20–7.50 (m, Ar–H), 13.65 (br s, N2–H,
T1A and T1B);
13C NMR (125.7 MHz, CDCl3) d 28.2 (CH3), 48.0 and
48.5 (NCH2 for T1A and T1B, respectively), 109.0 (C5),
111.7 (C2), 123.4 and 123.4 (C3 and C4), 127.5 (C14),
127.7 and 127.8 (C12/16 for T1B and T1A, respectively),
128.0 (C6), 128.8 and 128.9 (C13/15 for T1A and T1B,
respectively), 130.5 (C1), 138.7 (C11), 153.8 (C=N), 184.7
(C=S);
IR mmax: 3236, 3185, 3072, 3026, 2935, 1622, 1610,
1581, 1529, 1491, 1442, 1400, 1383, 1346, 1308, 1254,
1190, 1153, 1095, 1080, 931, 912, 739, 702, 656, 642, 621,
658, 571 cm-1
;
MS/MS (m/z) 297.3 (M ? 1), 295.2 (M - 1);
Anal. Calcd. for C16H16N4S: C, 64.84; H, 5.44; N,
18.90; S, 10.82%. Found: C, 64.86; H, 5.45; N, 19.01; S,
10.81%.
13C NMR (125.7 MHz, CDCl3): 28.1 (CH3), 46.5 and
47.0 (NCH2 for T1A and T1B, respectively), 108.8 and
109.0 (C5 for T1B and T1A, respectively), 111.3 and 111.7
(C2 for T1B and T1A, respectively), 116.8 and 117.0 (C12
for T1A and T1B, respectively), 123.1, 123.2, and 123.4
(C3/4 for T1A and T1B), 128.0 (C6), 130.5 (C1), 134.0
and 134.5 (C11 for T1B and T1A, respectively), 153.8
(C=N), 184.7 (C=S);
N-(1-methylbenzimidazolyl)-N0-phenethylthiourea 2c
Yield 63%; mp 141–142 °C;
UV [kmax, (lg e), solvent] 341 (5.60), CH3CN; 338
(2.59), CHCl3;
1H NMR (DMSO-d6) d 2.88, 2.90, 2.98 (3 9 t,
J = 7 Hz, PhCH2, T1A, T1B, and T1B), 3.52, 3.59, 3.74
(3 9 s, CH3, T1B, T1A, and T2A), 3.59, 3.70, 3.90
(3 9 q, J = 7 Hz, NHCH2, T1A, T1B, and T2A), 7.14–
7.62 (m, 9H, Ar–H), 8.10 (t, J = 6 Hz, N4–H, T1A), 8.42
(t, J = 6 Hz, N4–H, T1B), 10.70 (s, N4–H, T2A), 11.55
(t, J = 6 Hz, N3–H, T2A), 13.10 (s, N2–H, T1B), 13.27
(s, N2–H, T1A).
IR mmax 3230, 3174, 2989, 2925, 1624, 1612, 1581,
1514, 1479, 1446, 1429, 1402, 1377, 1332, 1315, 1294,
1254, 1242, 1192, 1163, 1144,1126, 1095, 1064, 999, 980,
941, 918, 874, 837, 812, 739, 661, 644, 611, 573 cm-1
;
MS/MS (m/z) 247.2 (M ? 1), 245.0 (M - 1);
Anal. Calcd. for C12H14N4S: C, 58.51; H, 5.73; N, 22.74;
S, 13.02%. Found: C, 58.56; H, 5.73; N, 22.74; S, 13.01%.
Aliphatic proton signals for 2c tautomers cannot be
assigned unambiguously owing to their nearly equal pop-
ulations (Table 1).
N-(1-methylbenzimidazolyl)-N’-benzylthiourea 2b
1H NMR (CDCl3) d 2.95 and 3.02 (2 9 t, J = 7 Hz,
PhCH2, T1A and T1B, respectively), 3.52 and 3.65 (2 9 s,
CH3, T1B and T1A, respectively), 3.80 and 3.95 (2 9 q,
Yield 59%; mp 161–163 °C;
UV [kmax, (lg e), solvent] 342 (4.98), CH3CN; 340
(3.55), CHCl3;
1H NMR (DMSO-d6) d 3.50, 3.53, 3.78 (3 9 s, CH3,
T1A, T1B, and T2A, respectively), 4.59, 4.75, 4.97
(3 9 d, J = 6 Hz, CH2NH, T1A, T1B, and T2A, respec-
tively), 7.13–7.60 (m, ArH), 8.55 (t, J = 6 Hz, N2–H,
T1A), 8.85 (t, J = 6 Hz, N2–H, T1B), 10.80 (s, N3–H,
T2A), 11.85 (t, J = 6 Hz, N4–H, T2A), 13.10 (s, N2–H,
T1B), 13.27 (s, N2–H, T1A);
Table 1 Solvent-dependent relative population (%) of isomers
1
derived from H NMR data for 2 (average results of CH3, CH2, and
NH proton signals integration; nd not detected)
Compound
CDCl3
DMSO-d6
T1A
T1B
T2A
T1A
T1B
T2A
2a
2b
2c
60
55
55
37
45
37
3
39
43
35
34
36
32
27
21
33
nd
7
15N NMR (DMSO-d6, CH3NO2) d -261.0 (N3 for
T2A), -257.5 (N2 for T1B), -256.0 (N2 for T1A),
123